Login/Sign Up
MRP ₹17874
(Inclusive of all Taxes)
₹2681.1 Cashback (15%)
Provide Delivery Location
Online payment accepted
Whats That
About Bdrelin-P 11.25 Injection Combipack 1's
Bdrelin-P 11.25 Injection Combipack 1's belongs to the class of 'anti-neoplastic agents', primarily used to treat prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Prostate cancer is the prostate gland's cancer (a small gland under the bladder secretes fluid that nourishes and protects sperm) found only in men. Endometriosis is a disorder in which tissue lining the uterus grows outside the uterine cavity. Precocious puberty occurs when a child's body changes into that of an adult or experiences puberty too soon.
Bdrelin-P 11.25 Injection Combipack 1's contains Triptorelin that belongs to the class of gonadotropin-releasing hormone (GnRH) agonists. Triptorelin is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. The lowering of testosterone hormone levels in men helps slows down the growth of cancer cells in prostate cancer.
Use Bdrelin-P 11.25 Injection Combipack 1's as prescribed by your doctor. Your doctor will decide the dosage depending on your medical condition. The common side effects of Bdrelin-P 11.25 Injection Combipack 1's include hot flashes, decreased sexual interest, shrinking of the testicles, breast tenderness or swelling, dizziness, headache, flu symptoms, nausea, vomiting, diarrhoea, upset stomach and swelling in legs. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Do not take or stop this medicine, if the doctor did not advise you to do so. Before starting Bdrelin-P 11.25 Injection Combipack 1's, let your doctor know if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Bdrelin-P 11.25 Injection Combipack 1's is not indicated for use in pregnant and breastfeeding women. Bdrelin-P 11.25 Injection Combipack 1's may make you feel dizzy, hence drive when you are alert only. Bdrelin-P 11.25 Injection Combipack 1's is not recommended for children below two years of age.
Uses of Bdrelin-P 11.25 Injection Combipack 1's
Directions for Use
Medicinal Benefits
Bdrelin-P 11.25 Injection Combipack 1's contains Triptorelin, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Bdrelin-P 11.25 Injection Combipack 1's is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Being an anti-neoplastic or anticancer agent, Bdrelin-P 11.25 Injection Combipack 1's works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. Bdrelin-P 11.25 Injection Combipack 1's reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helps in shrinking of endometriosis. Bdrelin-P 11.25 Injection Combipack 1's also has the role of a contraceptive drug.
Storage
Drug Warnings
Inform your doctor if you have any allergic reactions to Bdrelin-P 11.25 Injection Combipack 1's or other medications. Before starting Bdrelin-P 11.25 Injection Combipack 1's, let your doctor know if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Bdrelin-P 11.25 Injection Combipack 1's may cause QT prolongation (heart muscle takes longer than normal to recharge between beats) and may affect heart rhythm, hence heart patients should be cautious while taking Bdrelin-P 11.25 Injection Combipack 1's. Bdrelin-P 11.25 Injection Combipack 1's can affect the unborn baby when used in pregnancy. Hence, Bdrelin-P 11.25 Injection Combipack 1's is not indicated for use in pregnancy and breastfeeding women. If you are using Bdrelin-P 11.25 Injection Combipack 1's, make sure to use reliable forms of contraception to prevent pregnancy during the course. Bdrelin-P 11.25 Injection Combipack 1's may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Bdrelin-P 11.25 Injection Combipack 1's can make you feel dizzy and affects your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused. Bdrelin-P 11.25 Injection Combipack 1's is not recommended for children younger than two years of age.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Side Effects of Bdrelin-P 11.25 Injection Combipack 1's
Habit Forming
Therapeutic Class
Product Substitutes
We provide you with authentic, trustworthy and relevant information
Drug-Diseases Interactions
Login/Sign Up
Bdrelin-P 11.25 Injection Combipack 1's contains Triptorelin, a synthetic hormone. It helps reduce the testosterone and oestrogen hormones in men and women, respectively. This process of lowering hormone levels can decrease cancer cell's growth in prostate cancer in men and shrinks endometriosis in women.
Take the missed dose as soon as possible. However, if it is time for the next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose.
Bdrelin-P 11.25 Injection Combipack 1's should be used with caution and under doctor's supervision only if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Let your doctor know if you have any other medical concerns before using Bdrelin-P 11.25 Injection Combipack 1's.
During treatment with Bdrelin-P 11.25 Injection Combipack 1's in the first few weeks, a temporary increase in hormones may occur before they decrease. This may cause new or worsening of side effects of Bdrelin-P 11.25 Injection Combipack 1's. This is a normal response of your body to Bdrelin-P 11.25 Injection Combipack 1's. However, if you notice any symptoms that are not manageable, please seek medical advice.
Bdrelin-P 11.25 Injection Combipack 1's may worsen your mood disorders like depression. Hence it is advised to use Bdrelin-P 11.25 Injection Combipack 1's only when you are free from any kind of mental problems. Please consult your doctor for more information.
Bdrelin-P 11.25 Injection Combipack 1's may cause impotence and affect fertility in men. It is advised to speak to your doctor if you plan to have a family in the future before starting Bdrelin-P 11.25 Injection Combipack 1's.
Drug-Drug Interactions Checker List
Special Advise
Disease/Condition Glossary
Prostate cancer: It is the cancer of the prostate gland (a small gland under the bladder that secretes fluid that nourishes and protects sperm) found only in men. The symptoms include difficulty in urination, pain, numbness or sexual problems. It is the most common type of cancer in men.
Endometriosis: It is a disorder in which tissue lining the uterus grows outside the uterine cavity. It commonly involves ovaries, fallopian tubes and the tissue lining the pelvis. Symptoms of endometriosis include pain and irregular periods.
Precocious puberty occurs when a child's body changes into that of an adult or experiences puberty too soon. If puberty begins before age 8 in girls and before age 9 in boys, it is considered precocious puberty. Symptoms in a girl include first period and breast development, whereas, in boy, it causes enlarged testicles and penis, deepening voice and facial hair.
Have a query?
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Natco Pharma Ltd
Dr Reddy's Laboratories Ltd
Cipla Ltd
Celon Laboratories Pvt Ltd
Sun Pharmaceutical Industries Ltd
Alkem Laboratories Ltd
United Biotech Pvt Ltd
Zydus Cadila
Zydus Healthcare Ltd
Neon Laboratories Ltd
Glenmark Pharmaceuticals Ltd
Mylan Pharmaceuticals Pvt Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Emcure Pharmaceuticals Ltd
Adley Formulations
Samarth Life Sciences Pvt Ltd
Hetero Drugs Ltd
Torrent Pharmaceuticals Ltd
Fresenius Kabi India Pvt Ltd
Pfizer Ltd
Admac Lifesciences(Oncology)
Adley Pharmaceuticals Ltd
Novartis India Ltd
Halsted Pharma Pvt Ltd
Getwell Life Sciences India Pvt Ltd
Lupin Ltd
Cadila Healthcare Ltd
Hetero Healthcare Pvt Ltd
GLS Pharma Ltd
Reliance Formulation Pvt Ltd
Abbott India Ltd
Aimcad Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Therdose Pharma Pvt Ltd
Axiommax Oncology Pvt Ltd
Biochem Pharmaceutical Industries Ltd
Khandelwal Laboratories Pvt Ltd
Msn Laboratories Pvt Ltd
Aureate Healthcare
Caitlin Oncology
Dabur India Ltd
Zee Laboratories Ltd
Sarabhai Chemicals (India) Pvt Ltd
Wembrace Biopharma Pvt Ltd
Delarc Pharmaceuticals Pvt Ltd
Medaegis Biotek Pvt Ltd
Panacea Biotec Ltd
RPG Life Sciences Ltd
Shilpa Medicare Ltd
Getwell Oncology Pvt Ltd
Ipca Laboratories Ltd
Miracalus Pharma Pvt Ltd
Biocon Ltd
Cadila Pharmaceuticals Ltd
Eli Lilly and Company (India) Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Getwell Pharmaceutical Pvt Ltd
Maximal Healthcare Pvt Ltd
Boehringer Ingelheim India Pvt Ltd
Del Trade International Pvt Ltd
Sayre Therapeutics Pvt Ltd
Akumentis Healthcare Ltd
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Hilfen Pharmaceuticals Pvt Ltd
Johnson & Johnson Pvt Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Oncostar Pharma Pvt Ltd
Rhone Poulenc Rorer India Pvt Ltd
Vhb Life Sciences Inc
Zuventus Healthcare Ltd
Admac Pharma Ltd
Adonis Laboratories Pvt Ltd
Alniche Life Sciences Pvt Ltd
BPRL Pvt Ltd
Caitlin Life Care
Dr Care
German Remedies Ltd
Janssen Pharmaceuticals Pvt Ltd
MEDICAMEN BIOTECH LTD
Maxis Healthcare (I) Pvt Ltd
Pharm Products Pvt Ltd
Accord Life Spec Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Aphia Healthcare
Astellas Pharma India Pvt Ltd
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Bharat Serums and Vaccines Ltd
Cellgen Biopharma
Cosmic Life Sciences
Daris Biocare
East West Pharma India Pvt Ltd
Hillrock Biotech Pvt Ltd
Lucien Life Sciences
Maneesh Pharmaceuticals Ltd
Medilief Bioscience Pvt Ltd
Alcohol
Caution
It is advised to avoid alcohol consumption to minimize the unwanted effects of Bdrelin-P 11.25 Injection Combipack 1's. Please consult your doctor for more information.
Pregnancy
Unsafe
Bdrelin-P 11.25 Injection Combipack 1's is a pregnancy category X drug. It is unsafe to use Bdrelin-P 11.25 Injection Combipack 1's in pregnancy and can have harmful effects on the unborn baby. Use reliable forms of contraception to prevent pregnancy while using Bdrelin-P 11.25 Injection Combipack 1's.
Breast Feeding
Unsafe
Bdrelin-P 11.25 Injection Combipack 1's is unsafe to use during breastfeeding. Consult your doctor for further information.
Driving
Unsafe
Bdrelin-P 11.25 Injection Combipack 1's causes dizziness and affects your ability to drive. Do not drive or operate machinery if you experience any unmanageable side effects with Bdrelin-P 11.25 Injection Combipack 1's.
Liver
Caution
Please let your doctor know if you have any history of liver diseases or hepatic impairment before starting Bdrelin-P 11.25 Injection Combipack 1's.
Kidney
Caution
Please let your doctor know if you have any history of kidney diseases before starting Bdrelin-P 11.25 Injection Combipack 1's.
Children
Caution
Bdrelin-P 11.25 Injection Combipack 1's is not recommended in children younger than two years of age.